COSCIENS Biopharma Inc. (CSCIF) is a Health Care company in the Perfumes, Cosmetics & Other Toilet Preparations industry (SEC CIK 0001113423). Annual revenue was $0.01B in FY2025, compared to $0.01B in FY2021. Net income in FY2025 was $-0.01B (diluted EPS $-3.27).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.01B | $0.01B |
| Operating Income | $-0.01B | $-0.02B | $-0.00B | $0.00B | $-0.01B |
| Net Income | $-0.01B | $-0.02B | $-0.00B | $0.00B | $-0.01B |
| EPS (Diluted) | $-3.27 | $-5.93 | $-1.89 | $1.86 | $-1.82 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.02B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.01B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 35.3% | 49.3% |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001493152-26-012703 | Dec 31, 2025 | Mar 25, 2026 | Mar 25, 2026 21:05 UTC | EDGAR |
| 20-F | 0001641172-25-003456 | Dec 31, 2024 | Apr 9, 2025 | Apr 9, 2025 21:29 UTC | EDGAR |
| 20-F | 0001493152-24-011401 | Dec 31, 2023 | Mar 27, 2024 | Mar 27, 2024 12:05 UTC | EDGAR |
| 20-F | 0001493152-23-008641 | Dec 31, 2022 | Mar 23, 2023 | Mar 23, 2023 12:06 UTC | EDGAR |
| 20-F | 0001493152-22-007933 | Dec 31, 2021 | Mar 29, 2022 | Mar 29, 2022 01:33 UTC | EDGAR |
| 20-F | 0001493152-20-005347 | Dec 31, 2019 | Mar 31, 2020 | Mar 31, 2020 00:42 UTC | EDGAR |
| 20-F | 0001628280-19-003681 | Dec 31, 2018 | Apr 1, 2019 | Mar 29, 2019 23:43 UTC | EDGAR |
| 20-F | 0001628280-18-003635 | Dec 31, 2017 | Mar 28, 2018 | Mar 28, 2018 11:19 UTC | EDGAR |
Direct links to SEC EDGAR. CSCIF has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $0.04B |
| $0.02B |
| $0.03B |
| $0.08B |
| Total Liabilities | $0.02B | $0.02B | $0.00B | $0.00B | $0.03B |
|---|
| Stockholders' Equity | $0.00B | $0.01B | $0.02B | $0.02B | $0.02B |
|---|
| Cash & Equivalents | $0.01B | $0.02B | $0.01B | $0.01B | $0.01B |
|---|
| Total Debt | — | — | — | — | — |
|---|
| $-0.01B |
| $-0.00B |
| $0.01B |
| $-0.01B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
|---|
| Free Cash Flow | $-0.01B | $-0.02B | $-0.00B | $0.00B | $-0.01B |
|---|
| 41.1% |
| 75.6% |
| 98.3% |
| Operating Margin | -0.2% | -0.3% | -0.2% | 0.5% | -0.0% |
|---|
| Net Margin | -0.2% | -0.3% | -0.3% | 0.4% | -0.0% |
|---|
| Return on Equity | -269.6% | -116.3% | -16.6% | 14.5% | -38.1% |
|---|
| Return on Assets | -48.3% | -43.7% | -14.7% | 12.4% | -10.4% |
|---|
| Debt / Equity | 4.58× | 1.66× | 0.13× | 0.17× | 1.24× |
|---|
